Fangyi Zhu
- Organic Chemistry top 10%
- Synthesis and Biological Evaluation 8
- Oncology top 10%
- Cancer-related Molecular Pathways 5
- Ophthalmology top 5%
- Biotechnology top 10%
-
- Research on Leishmaniasis Studies 9
- Malaria Research and Control 6
-
- Trypanosoma species research and implications 9
-
- Estrogen and related hormone effects 4
-
- Ubiquitin and proteasome pathways 3
-
- Traditional Chinese Medicine Studies 3
- Co-authors
- R. Kiplin GuyMichele ConnellyLeggy A. ArnoldMichael A. DyerAnang A. ShelatW. Armand GuiguemdeJong Yeon HwangDavid C. Smithson
- Partner nations
- United StatesChinaSwitzerland
In The Last Decade
Fangyi Zhu
38 papers receiving 988 citations
Peers
Comparison fields: 5 of 100
- Organic Chemistry 317
- Oncology 270
- Ophthalmology 77
- Biotechnology 56
- Public Health, Environmental and Occupational Health 186
Countries citing papers authored by Fangyi Zhu
This map shows the geographic impact of Fangyi Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangyi Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangyi Zhu more than expected).
Fields of papers citing papers by Fangyi Zhu
This network shows the impact of papers produced by Fangyi Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangyi Zhu. The network helps show where Fangyi Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fangyi Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 8 | |
| 7 | 2022 | 6 | |
| 8 | 2021 | 10 | |
| 9 | 2017 | 29 | |
| 10 | 2014 | 17 | |
| 11 | 2013 | 11 | |
| 12 | 2011 | 71 | |
| 13 | 2011 | 31 | |
| 14 | 2010 | 46 | |
| 15 | 2010 | 6 | |
| 16 | 2010 | 159 | |
| 17 | 2009 | 8 | |
| 18 | 2009 | 6 | |
| 19 | 2009 | 17 | |
| 20 | 2008 | 50 |
About Fangyi Zhu
Fangyi Zhu is a scholar working on Public Health, Environmental and Occupational Health, Organic Chemistry and Complementary and alternative medicine, having authored 42 papers that have together received 1.0k indexed citations. Recurring topics across this work include Research on Leishmaniasis Studies (9 papers), Trypanosoma species research and implications (9 papers), Synthesis and Biological Evaluation (8 papers), Malaria Research and Control (6 papers), Cancer-related Molecular Pathways (5 papers), Estrogen and related hormone effects (4 papers), Ubiquitin and proteasome pathways (3 papers) and Traditional Chinese Medicine Studies (3 papers). The work is most often cited by research in Organic Chemistry (317 citations), Oncology (270 citations) and Ophthalmology (77 citations). Fangyi Zhu has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include R. Kiplin Guy, Michele Connelly, Leggy A. Arnold, Michael A. Dyer, Anang A. Shelat, W. Armand Guiguemde, Jong Yeon Hwang, David C. Smithson, Aaron Kosinski and Martina Sigal. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.